The clinical trial will investigate a preventive vaccine designed to recognise multiple mutated proteins frequently found in patients with Lynch syndrome.
They are hoping to immunise patients who are cancer-free with those shared foreign mutated proteins so that the immune system will be prepared, if a patient develops a tumour, to reject it.
Lynch Syndrome Ireland 